Discover 2,122 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,122
Brain Activity Changes After Cognitive Behavioral Therapy for Anxiety in Autistic Youth From High-Need Communities
for
Autism Spectrum Disorder, Anxiety
Location: Philadelphia PA, Montclair NJ
Sponsor: Montclair State University
Sex: All
Age: 8 - 14
Code: NCT06904508
Recruiting
Augmenting Cognitive Behavioral Therapy With Inhibitory Control Training
for
Binge-Eating Disorder, Bulimia Nervosa
Location: Philadelphia PA
Sponsor: Drexel University
Sex: All
Age: 18 - 55
Code: NCT04076553
Recruiting
Environmental and Sensory Intervention for Nursing Home Residents With Dementia Who Exhibit Persistent Vocalizations
for
Dementia
Location: Philadelphia PA
Sponsor: Drexel University
Sex: All
Age: 50+
Code: NCT06568107
Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Location: Wilkes-Barre PA, Philadelphia PA, East Brunswick NJ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07431281
Phase 3, Recruiting
New
Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation
for
Recurrent Soft Tissue Sarcoma of the Trunk and Extremities,
Location: Wilkes-Barre PA, Philadelphia PA, Chadds Ford PA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07615049
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Vitamin D for Prostate Endocrine Therapy
for
Stage I Prostate Cancer AJCC v8,
Location: Wilkes-Barre PA, Scranton PA, Dickson City PA,
Sponsor: University of Rochester
Sex: Male
Age: 50+
Code: NCT05838716
Phase 3, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
for
Myelodysplastic Syndrome
Location: Wilkes-Barre PA, New Brunswick NJ, Livingston NJ,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06577441
Phase 2, Recruiting
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
for
AL Amyloidosis
Location: Wilkes-Barre PA, Philadelphia PA, Danville PA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06022939
Phase 3, Recruiting
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
for
Lymphoma, Malignant Solid Neoplasm
Location: Wilkes-Barre PA, Scranton PA, Dickson City PA,
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT05006482
Phase 3, Recruiting
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
for
Advanced Colorectal Carcinoma,
Location: Wilkes-Barre PA, Wilmington DE, Danville PA, Newark DE,
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT06073431
Recruiting
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
for
Malignant Digestive System Neoplasm,
Location: Wilkes-Barre PA, Scranton PA, Danville PA, Newark DE,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT07215624
Recruiting
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Wilkes-Barre PA, Philadelphia PA, Providence RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 60+
Code: NCT07437950
Phase 2, Recruiting
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Wilkes-Barre PA, Chadds Ford PA, Wilmington DE,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18 - 70+
Code: NCT06724237
Phase 3, Recruiting
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
for
Advanced Hepatocellular Carcinoma,
Location: Wilkes-Barre PA, Chadds Ford PA, Dickson City PA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07166406
Phase 3, Recruiting
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Wilkes-Barre PA, Philadelphia PA, Danville PA,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT06686771
Phase 3, Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
for
Core Binding Factor Acute Myeloid Leukemia
Location: Wilkes-Barre PA, Danville PA, The Bronx NY, Syracuse NY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT06917911
Phase 2, Recruiting
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
for
Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma,
Location: Wilkes-Barre PA, Philadelphia PA, Danville PA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05633615
Phase 2, Recruiting
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases